JIANGXI LITIAN WEIKANG SCIENCE & TECHNOLOGY CO.,LTD

Jiangxi Litian Weikang Technology Co., Ltd. was jointly invested and established in July 2010 by Mr. Xu Bubin, a Ph.D. who studied in the United States, and Hangzhou Weikang Technology and Shanghai Litian Chemical. It is a research-based enterprise integrating high-end pharmaceutical intermediates process research, development, production and sales. The company is located in Guixi Industrial Park, Jiangxi Province, covers an area of ​​38.2 acres, and is expected to have nearly 100 employees. The company mainly exports chemicals for export, and also provides pharmaceutical intermediates products and technical services to large domestic pharmaceutical companies. The company is mainly engaged in the commercial production of new pharmaceutical intermediates. Products such as sarpogrelate hydrochloride intermediates, lumefantrine intermediates, 2-cyanopyrimidine intermediates, urodil intermediates, 10t/a aprindine intermediates, 2-anilinoindene, lafutidine series intermediates and alosetron intermediates, N-methylphenylhydrazine and its sulfate are basically all exported to Europe, America and Southeast Asia. In particular, the technology of the sarpogrelate hydrochloride series intermediates and lumefantrine series intermediates developed and produced by the company is at the world's leading level. The quality and cost of the products have considerable advantages over those of its peers and occupy a high market share.